{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:31:08Z","timestamp":1761514268932,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.nec.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T21:18:30Z","timestamp":1537046310000},"page":"517-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of Antiplatelet Agents in the Neurosurgical Patient"],"prefix":"10.1016","volume":"29","author":[{"given":"Amanda S.","family":"Zakeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahid M.","family":"Nimjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nec.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of platelet IIb\/IIIa inhibition for prevention of ischemic complication","volume":"278","author":"Topol","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.nec.2018.06.004_bib2","article-title":"Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel","author":"Choi","year":"2017","journal-title":"Neurosurgery December"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3171\/2012.8.JNS12185","article-title":"Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques","volume":"117","author":"Rossen","year":"2012","journal-title":"J Neurosurg"},{"issue":"9","key":"10.1016\/j.nec.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3174\/ajnr.A4365","article-title":"Complications in Stent-Assisted Endovascular Therapy of Ruptured Intracranial Aneurysms and Relevance to Antiplatelet Administration: A Systematic Review","volume":"36","author":"Ryu","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"12","key":"10.1016\/j.nec.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current Role of Platelet Glycoprotein IIb\/IIIa Inhibitors in Acute Coronary Syndromes","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.nec.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.98.25.2829","article-title":"Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb\/IIIa integrin in ischemic heart disease","volume":"98","author":"Kong","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0735-1097(00)00554-4","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade in coronary artery disease","volume":"35","author":"Lincoff","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"7329","key":"10.1016\/j.nec.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/neuros\/nyx170","article-title":"Glycoprotein IIb\/IIIa inhibitors in prevention and rescue treatment of thromboembolic complications during endovascular embolization of intracranial aneurysms","volume":"82","author":"Dornbos","year":"2018","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/neurintsurg-2014-011145","article-title":"Effect of antiplatelet therapy and platelet function testing on hemorrhagic and thrombotic complications in patients with cerebral aneurysms treated with the pipeline embolization device: a review and meta-analysis","volume":"8","author":"Skukalek","year":"2016","journal-title":"J\u00a0Neurointerv Surg"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1148\/radiol.13120099","article-title":"Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial","volume":"267","author":"Becske","year":"2013","journal-title":"Radiology"},{"issue":"Suppl 3","key":"10.1016\/j.nec.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1136\/neurintsurg-2012-010582","article-title":"Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device","volume":"5","author":"Delgado Almandoz","year":"2013","journal-title":"J\u00a0Neurointerv Surg"},{"key":"10.1016\/j.nec.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clineuro.2017.08.003","article-title":"Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: a systematic literature review","volume":"161","author":"Texakalidis","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1227\/NEU.0000000000000978","article-title":"P2Y12 reaction units: effect on hemorrhagic and thromboembolic complications in patients with cerebral aneurysms treated with the pipeline embolization device","volume":"78","author":"Daou","year":"2016","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3174\/ajnr.A3621","article-title":"Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device","volume":"35","author":"Delgado Almandoz","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/STROKEAHA.116.015308","article-title":"Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study","volume":"48","author":"Adeeb","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.nec.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.wneu.2017.07.019","article-title":"Safety and efficacy of a 600-mg loading dose of clopidogrel 24 hours before pipeline embolization device treatment","volume":"106","author":"Atallah","year":"2017","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/neurintsurg-2014-011111","article-title":"Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value","volume":"7","author":"Tan","year":"2015","journal-title":"J\u00a0Neurointerv Surg"},{"issue":"11","key":"10.1016\/j.nec.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/neurintsurg-2016-012701","article-title":"Early angiographic signs of acute thrombus formation following cerebral aneurysm treatment with the Pipeline embolization device","volume":"9","author":"Patel","year":"2017","journal-title":"J\u00a0Neurointerv Surg"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0b013e318203f38d","article-title":"Antiplatelet drugs: a review of their pharmacology and management in the perioperative period","volume":"112","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1227\/NEU.0000000000001071","article-title":"A\u00a0new protocol for anticoagulation with tirofiban during flow diversion","volume":"78","author":"Chalouhi","year":"2016","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.nec.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(15)70018-9","article-title":"Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial","volume":"14","author":"Markus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.STR.26.2.235","article-title":"Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients","volume":"26","author":"Biousse","year":"1995","journal-title":"Stroke"},{"issue":"21","key":"10.1016\/j.nec.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/WNL.0b013e3181a2a50a","article-title":"Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients","volume":"72","author":"Georgiadis","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nec.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1474-4422(09)70084-5","article-title":"Cervical-artery dissections: predisposing factors, diagnosis, and outcome","volume":"8","author":"Debette","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2011.07.031","article-title":"Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease","volume":"54","author":"Ricotta","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"issue":"8","key":"10.1016\/j.nec.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2010.11.005","volume":"57","author":"Brott","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.nec.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-1331.2003.00646.x","article-title":"Neurovascular territory involved in different etiological subtypes of ischemic stroke in the Perugia Stroke Registry","volume":"10","author":"Paciaroni","year":"2003","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.nec.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.STR.19.9.1083","article-title":"The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke","volume":"19","author":"Bogousslavsky","year":"1988","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/WCO.0b013e328012da60","article-title":"Asymptomatic carotid stenosis: what to do","volume":"20","author":"Redgrave","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"10.1016\/j.nec.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1161\/STROKEAHA.109.556068","article-title":"Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis","volume":"40","author":"Abbott","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib33","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1161\/STROKEAHA.109.561837","article-title":"Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study","volume":"41","author":"Marquardt","year":"2010","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/STROKEAHA.110.578856","article-title":"Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis","volume":"41","author":"Woo","year":"2010","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.nec.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000367988","article-title":"Antithrombotic therapy in carotid artery stenosis: an update","volume":"73","author":"Paciaroni","year":"2015","journal-title":"Eur Neurol"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejrad.2006.05.021","article-title":"The evidence for medicine versus surgery for carotid stenosis","volume":"60","author":"Ederle","year":"2006","journal-title":"Eur J Radiol"},{"issue":"9","key":"10.1016\/j.nec.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-123-9-199511010-00002","article-title":"Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group","volume":"123","author":"C\u00f4t\u00e9","year":"1995","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.nec.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the primary prevention of stroke","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"},{"issue":"18","key":"10.1016\/j.nec.2018.06.004_bib39","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.nec.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0025-6196(11)60546-6","article-title":"Treatment of carotid artery stenosis: medical therapy, surgery, or stenting?","volume":"84","author":"Lanzino","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"16","key":"10.1016\/j.nec.2018.06.004_bib41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.nec.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.nec.2018.06.004_bib43","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"9431","key":"10.1016\/j.nec.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.nec.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.22.10.1229","article-title":"Carotid surgery versus medical therapy in asymptomatic carotid stenosis. The CASANOVA Study Group","volume":"22","year":"1991","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.nec.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/157016112803520800","article-title":"Treatment of carotid stenosis","volume":"10","author":"Touze","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"issue":"9596","key":"10.1016\/j.nec.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(07)61448-2","article-title":"Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison","volume":"370","author":"Rothwell","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"issue":"suppl_G","key":"10.1016\/j.nec.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1093\/eurheartj\/sul054","article-title":"Bleeding and management of bleeding","volume":"8","author":"Eikelboom","year":"2006","journal-title":"Eur Heart J Suppl"},{"issue":"6 Suppl","key":"10.1016\/j.nec.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"630S","DOI":"10.1378\/chest.08-0720","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)","volume":"133","author":"Albers","year":"2008","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.nec.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.STR.30.9.1991","article-title":"Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association","volume":"30","author":"Wolf","year":"1999","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.20942","article-title":"National Stroke Association guidelines for the management of transient ischemic attacks","volume":"60","author":"Johnston","year":"2006","journal-title":"Ann Neurol"},{"issue":"17","key":"10.1016\/j.nec.2018.06.004_bib53","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.nec.2018.06.004_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000351686","article-title":"Antiplatelet therapy for carotid artery stenting","volume":"1","author":"Enomoto","year":"2012","journal-title":"Interv Neurol"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejvs.2005.01.012","article-title":"The benefits of combined anti-platelet treatment in carotid artery stenting","volume":"29","author":"McKevitt","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","article-title":"Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan Stroke Study","volume":"26","author":"Sacco","year":"1995","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.nec.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.45.8.1488","article-title":"The warfarin-aspirin symptomatic intracranial disease study","volume":"45","author":"Chimowitz","year":"1995","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nec.2018.06.004_bib58","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/01.STR.29.7.1389","article-title":"Prognosis of patients with symptomatic vertebral or basilar artery stenosis","volume":"29","year":"1998","journal-title":"Stroke"},{"issue":"13","key":"10.1016\/j.nec.2018.06.004_bib59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/STROKEAHA.108.528281","article-title":"Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis","volume":"40","author":"Turan","year":"2009","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.nec.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/01.wnl.0000238506.76873.2f","article-title":"Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID","volume":"67","author":"Kasner","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nec.2018.06.004_bib62","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nec.2018.06.004_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fneur.2014.00101","article-title":"Reviving intracranial angioplasty and stenting \u201cSAMMPRIS and beyond.\u201d","volume":"5","author":"Farooq","year":"2014","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1474-4422(10)70060-0","article-title":"Clopidogrel plus\u00a0aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial","volume":"9","author":"Wong","year":"2010","journal-title":"Lancet Neurol"},{"issue":"Suppl A100","key":"10.1016\/j.nec.2018.06.004_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/ijs.12003","article-title":"Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study","volume":"9","author":"Lau","year":"2014","journal-title":"Int J Stroke"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000369524","article-title":"Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China","volume":"39","author":"Bao","year":"2015","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.2008.145078","article-title":"Changing ischaemic lesion patterns in adult moyamoya disease","volume":"80","author":"Kim","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.197.1.7568830","article-title":"Posterior circulation in moyamoya disease: angiographic study","volume":"197","author":"Yamada","year":"1995","journal-title":"Radiology"},{"issue":"1\u20132","key":"10.1016\/j.nec.2018.06.004_bib69","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jns.2015.11.018","article-title":"Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease","volume":"359","author":"Noh","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"issue":"Suppl 2","key":"10.1016\/j.nec.2018.06.004_bib70","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1016\/S0303-8467(97)00082-6","article-title":"Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (\u2019moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan","volume":"99","author":"Fukui","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.nec.2018.06.004_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","article-title":"Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry Study of Research Committee on Moyamoya Disease in Japan","volume":"25","author":"Yamada","year":"2016","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib72","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s007010050035","article-title":"Neovascularization (angiogenesis) after revascularization in moyamoya disease. Which technique is most useful for moyamoya disease?","volume":"142","author":"Houkin","year":"2000","journal-title":"Acta Neurochir"},{"issue":"10","key":"10.1016\/j.nec.2018.06.004_bib73","first-page":"734","article-title":"How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography","volume":"20","author":"Houkin","year":"2004","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib74","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/STROKEAHA.107.497271","article-title":"Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review","volume":"39","author":"O\u2019Donnell","year":"2008","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib75","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000000076","article-title":"ASA failure: does the combination ASA\/clopidogrel confer better long-term vascular protection?","volume":"82","author":"C\u00f4t\u00e9","year":"2014","journal-title":"Neurology"},{"issue":"9038","key":"10.1016\/j.nec.2018.06.004_bib76","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"9066","key":"10.1016\/j.nec.2018.06.004_bib77","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes","volume":"132","author":"Wang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nec.2018.06.004_bib80","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","author":"Johnston","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"9523","key":"10.1016\/j.nec.2018.06.004_bib81","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.nec.2018.06.004_bib82","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.nec.2018.06.004_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J\u00a0Neurol Sci"},{"issue":"5","key":"10.1016\/j.nec.2018.06.004_bib84","first-page":"367","article-title":"Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial","volume":"138","author":"Guiraud-Chaumeil","year":"1982","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.nec.2018.06.004_bib85","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","article-title":"Persantine Aspirin Trial in cerebral ischemia. Part II: endpoint results. The American-Canadian Co-Operative Study group","volume":"16","year":"1985","journal-title":"Stroke"},{"issue":"19","key":"10.1016\/j.nec.2018.06.004_bib86","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"Bhatt","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.nec.2018.06.004_bib87","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N\u00a0Engl J Med"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368018308672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368018308672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:00:52Z","timestamp":1760904052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368018308672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1042368018308672"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2018.06.004","relation":{},"ISSN":["1042-3680"],"issn-type":[{"type":"print","value":"1042-3680"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Antiplatelet Agents in the Neurosurgical Patient","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}